Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients

Journal of Neurosurgery - Tập 112 Số 5 - Trang 990-996 - 2010
Seunggu J. Han1, Isaac Yang2,3, José Javier Otero4, Brian Ahn2,3, Tarık Tihan4, Michael W. McDermott2,3, Mitchel S. Berger2,3, Susan M. Chang2,3, Andrew T. Parsa2,3
1Department of Neurological Surgery, University of California, San Francisco, California 94117, USA.
2Departments of Neurological Surgery, and
3University of California at San Francisco
42Pathology, University of California, San Francisco, California

Tóm tắt

Object Gliosarcoma can arise secondarily, after conventional adjuvant treatment of high-grade glioma. The current literature on the occurrence of secondary gliosarcoma (SGS) after glioblastoma multiforme (GBM) is limited, with only 12 reported cases. The authors present a large series of histologically confirmed SGSs, with follow-up to describe the clinical and radiological presentation, pathological diagnosis, and treatment outcomes. Methods Gliosarcoma cases were identified using the University of California, San Francisco's Departments of Neurological Surgery and Neuropathology databases. Through a retrospective chart review, cases of gliosarcoma were considered SGS if the following inclusion criteria were met: 1) the patient had a previously diagnosed intracranial malignant glioma that did not have gliosarcoma components; and 2) the histopathological tissue diagnosis of the recurrence confirmed gliosarcoma according to the most current WHO criteria. Extensive review of clinical, surgical, and pathology notes was performed to gather clinical and pathological data on these cases. Results Thirty consecutive patients in whom SGS had been diagnosed between 1996 and 2008 were included in the analysis. All patients had previously received a diagnosis of malignant glioma. For the initial malignant glioma, all patients underwent resection, and 25 patients received both external-beam radiation and chemotherapy. Three patients received radiotherapy alone, 1 patient was treated with chemotherapy alone, and 1 patient's tumor rapidly recurred as gliosarcoma, requiring surgical intervention prior to initiation of adjuvant therapy. The median time from diagnosis of the initial tumor to diagnosis of gliosarcoma was 8.5 months (range 0.5–25 months). All but 1 patient (who only had a biopsy) underwent a second operation for gliosarcoma; 8 patients went on to receive radiotherapy (4 had brachytherapy, 3 had external-beam radiation, and 1 had Gamma Knife surgery); and 14 patients received additional chemotherapy. The median length of survival from the time of gliosarcoma diagnosis was 4.4 months (range 0.7–46 months). The median survival from the time of the original GBM diagnosis was 12.6 months (range 5.7–47.4 months). Patients who had received concurrent and adjuvant temozolomide for GBM had worse outcomes than those who had not (4.3 and 10.5 months, respectively; p = 0.045). There was no difference in time to diagnosis of gliosarcoma in these 2 groups (8 and 8.5 months; p = 0.387). Two patients who had not received radiation therapy for GBM had an anecdotally very prolonged survival (20.9 and 46.4 months). Conclusions The data underscore the difficulty associated with management of this disease. The strikingly poor survival of patients with SGS who had previously received combined radiation and temozolomide chemotherapy for GBM may reflect a unique molecular profile of GBM that eventually recurs as SGS. Further work will be required, controlling for multiple prognostic factors with larger numbers of patients.

Từ khóa


Tài liệu tham khảo

Actor, 2002, Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components, 34, 416

Beaumont, 2007, Glioblastoma with multiple extracranial metastases: case report and review of literature, 83, 39

Biernat, 1995, Identical mutations of the p53 tumor suppressor gene in the gliomatous and the sarcomatous components of gliosarcomas suggest a common origin from glial cells, 54, 651

Cervoni, 1996, Cerebral gliosarcoma: prognostic factors, 19, 93

Deb, 2006, Giant cell glioblastoma multiforme: report of a case with prolonged survival and transformation to gliosarcoma, 22, 314

Feigin, 1955, Sarcoma arising in glioblastoma of the brain, 31, 633

Galanis, 1998, Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results, 89, 425

Han, 2009, Primary gliosarcoma: key clinical and pathologic distinctions from glioblastoma with implications as a unique oncologic entity

Han, 2009, Secondary gliosarcoma: a review of clinical features and pathologic diagnosis

Kozak, 2009, Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome, 11, 183

Lieberman, 2001, Postradiation gliosarcoma with osteosarcomatous components, 43, 555

Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, 114, 97

Lutterbach, 2001, Gliosarcoma: a clinical study, 61, 57

Maiuri, 1990, Cerebral gliosarcomas: correlation of computed tomographic findings, surgical aspect, pathological features, and prognosis, 26, 261

Meis, 1991, Mixed glioblastoma multiforme and sarcoma: a clinicopathologic study of 26 Radiation Therapy Oncology Group Cases, 67, 2342

Miller, 2007, Glioblastoma: morphologic and molecular genetic diversity, 131, 397

Morantz, 1976, Clinical and pathological study of 24 cases of gliosarcoma, 45, 398

Parekh, 1995, Primary cerebral gliosarcoma: report of 17 cases, 9, 171

Perry, 1995, Clinicopathologic features of primary and postirradiation cerebral gliosarcoma, 75, 2910

Rodriguez, 2008, Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study, 113, 2779

Salvati, 2005, Gliosarcomas: analysis of 11 cases do two subtypes exist?, 74, 59

Sarkar, 1997, A clinicopathological study of 29 cases of gliosarcoma with special reference to two unique variants, 106, 229

Slowik, 1980, Extracranial spreading of glioblastoma multiforme, 41, 57

Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, 352, 987

Weaver, 1984, Selective peripancreatic sarcoma metastases from primary gliosarcoma, 61, 599

Thông tin
Thông tin xuất bản

Journal of Neurosurgery

Tập 112 Số 5

990-996

Thông tin tác giả